Skip to main content
Clinical Trials/NCT01617564
NCT01617564CompletedNot Applicable

Paracervical Block (PCB) During II-trimester Abortion- A Randomized Controlled Trial

Kristina Gemzell Danielsson2 sites in 1 country112 target enrollmentStarted: May 2012Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
112
Locations
2
Primary Endpoint
Pain score

Study Overview

Brief Summary

Paracervical blockage can reduce severe pain during second trimester induced medical abortion.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Women who request second trimester medical abortion (13-22 weeks gestation according to ultrasound)
  • 18 years of age or older
  • able to understand and communicate in Swedish
  • able to understand the study related information and willing to give her
  • informed consent to participation in the study

Exclusion Criteria

  • Known allergy to bupivakain or related substances

Arms & Interventions

Bupivacain

Active Comparator

Intervention: bipuvacain (Drug)

Sodium Chloride

Sham Comparator

Intervention: NaCl (Other)

Outcomes

Primary Outcomes

Pain score

Time Frame: at 24 hours

Pain indicated on VAS at specific time intervals during the induction to expulsion

Secondary Outcomes

  • Efficacy(after 24h from induction)
  • Time to abortion(at 24hours)
  • Number of Participants with Adverse Events as a Measure of Safety and Tolerability(at 6 to 8 weeks)

Investigators

Sponsor
Kristina Gemzell Danielsson
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Kristina Gemzell Danielsson

Professor

Karolinska Institutet

Study Sites (2)

Loading locations...

Similar Trials

Paracervical Block During II-trimester... | Clinical Trial